These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 84801)

  • 1. In vitro histamine and serotonin release studies in atopic dermatitis.
    Ring J; O'Connor R
    Int Arch Allergy Appl Immunol; 1979; 58(3):322-30. PubMed ID: 84801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered releasability of vasoactive mediator secreting cells in atopic eczema.
    Ring J; Dorsch W
    Acta Derm Venereol Suppl (Stockh); 1985; 114():9-23. PubMed ID: 2408433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro releasability of histamine and serotonin: studies of atopic patients.
    Ring J; Allen DH; Mathison DA; Spiegelberg HL
    J Clin Lab Immunol; 1980 Mar; 3(2):85-91. PubMed ID: 6162959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro effect of levamisole on lymphocyte proliferation, polymorphonuclear leucocyte chemotaxis, basophil histamine release and platelet serotonin release in patients with atopic dermatitis.
    O'Connor RD; Ring J; Jalowayski AA; Hamburger RN
    Clin Allergy; 1980 Nov; 10(6):705-13. PubMed ID: 6161718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
    Butler JM; Chan SC; Stevens S; Hanifin JM
    J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine leucocyte histamine release: response to antigen and to anti-IgE.
    Jackson HA; Miller HR; Halliwell RE
    Vet Immunol Immunopathol; 1996 Oct; 53(3-4):195-206. PubMed ID: 8969041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome.
    Ruzicka T; Glück S
    Arch Dermatol Res; 1983; 275(1):41-4. PubMed ID: 6189456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basophil mediator release in atopic dermatitis.
    Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
    J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased release of lysosomal enzymes from peripheral leukocytes of patients with atopic dermatitis.
    Ring J; Lutz J
    J Am Acad Dermatol; 1983 Mar; 8(3):378-85. PubMed ID: 6833538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased vasoactive mediator releasability: a possible pathogenic factor of atopic dermatitis.
    Ring J
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():156-8. PubMed ID: 6171523
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity.
    Sampson HA; Broadbent KR; Bernhisel-Broadbent J
    N Engl J Med; 1989 Jul; 321(4):228-32. PubMed ID: 2473400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells.
    Ring J; Arroyave CM; Frizler MJ; Tan EM
    Clin Exp Immunol; 1978 Apr; 32(1):105-18. PubMed ID: 78780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine and atopic eczema.
    Ring J; Thomas P
    Acta Derm Venereol Suppl (Stockh); 1989; 144():70-7. PubMed ID: 2477978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma histamine concentrations in atopic eczema.
    Ring J
    Clin Allergy; 1983 Nov; 13(6):545-52. PubMed ID: 6640890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro study of IgE production in severe atopic dermatitis.
    Hovmark A
    Acta Derm Venereol; 1979; 59(3):223-7. PubMed ID: 87079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Butler JM; Ebertz M; Chan SC; Stevens SR; Sobieszczuk D; Hanifin JM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():55-60. PubMed ID: 2408432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
    Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
    Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopharmacology of the atopic diseases.
    Hanifin JM; Butler JM; Chan SC
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):161s-164s. PubMed ID: 2409183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cyclic nucleotide responsiveness of leukocytes and platelets in patients suffering from atopic dermatitis.
    Ring J; Mathison DA; O'Connor R
    Int Arch Allergy Appl Immunol; 1981; 65(1):1-7. PubMed ID: 6260691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis.
    Sampson HA; Jolie PL
    N Engl J Med; 1984 Aug; 311(6):372-6. PubMed ID: 6204202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.